Page contentsPage contents Key facts Decision Key facts Active substance evenamide Therapeutic area Nervous system disorders Decision number EMA/PE/0000223288 PIP number EMA/PE/0000223288 Pharmaceutical form(s) Capsule, hard Condition(s) / indication(s) Treatment of schizophrenia Route(s) of administration Oral use Contact for public enquiries Newron Pharmaceuticals S.p.A. E-mail: ravi@anand.chTel: +39026103461 Decision type PM: decision on the application for modification of an agreed PIP Decision date 03/01/2025 Compliance check done No Decision EMA/PE/0000223288 : EMA decision of 3 January 2025 on the acceptance of a modification of an agreed paediatric investigation plan for evenamideAdopted Reference Number: EMADOC-1700519818-1802284 English (EN) (239.61 KB - PDF)First published: 05/03/2026 View Share this page